Dapagliflozin reduced the combined risk of worsening heart failure

Dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death among patients with heart failure and a mildly reduced or preserved ejection fraction.

Leave a Reply

Your email address will not be published.

Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest product or an exclusive offer.